AbbVie Raises Full-Year Revenue Guidance and Announces Dividend Increase
AbbVie (ABBV) has reported strong third-quarter performance, leading management to raise its full-year revenue guidance to $67.8 billion. The company also provided an updated outlook for 2026, projecting adjusted earnings per share (EPS) in the range of $13.95 to $13.99. CEO and Chairman Robert Michael noted that the company is performing above expectations. In addition to the improved financial guidance, AbbVie announced an increase in its quarterly dividend, signaling confidence in its ongoing cash flow and operational strength.
Tickers: $ABBV
Topics: dividend increase earnings report guidance raise quarterly results